Pharmacokinetics of ASP2215
1 clinical trials · Condition
◉ Watch Pharmacokinetics of ASP2215
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function (NCT04699877) | Astellas Pharma Global Development, Inc. | 2021-01-28 |
Track Pharmacokinetics of ASP2215 automatically
Every clearance here is in the API, with alerts when new ones post.